Rebecca Dent, MD, MSc, of the National Cancer Center in Singapore, gives insights on the use of antibody-drug conjugates (ADCs) in early breast cancer treatment.
Rebecca Dent, MD, MSc
Advertisement
Rebecca Dent, MD, MSc, is deputy CEO and senior consultant at the National Cancer Center in Singapore.
Articles by Rebecca Dent, MD, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Enfortumab Vedotin Plus Pembro Cuts Risk of Disease Progression, Death 60% for Patients With MIBC Who Can’t Have Chemo With Bladder Removal
2
Sexual Dysfunction From Cancer Is Widespread—and Many Don’t Know That Before Treatment, Data Show
3
Enzalutamide Combo Improves OS in Prostate Cancer Without Sacrificing Quality of Life: Stephen Freedland, MD
4
The Growing ADC Landscape in TNBC Brings Questions, Opportunities: Rebecca Dent, MD, MSc
5
